|1.||Oyama, Tohru: 3 articles (06/2009 - 01/2005)|
|2.||Hisamitsu, T: 3 articles (05/2004 - 02/2001)|
|3.||Asano, K: 3 articles (05/2004 - 02/2001)|
|4.||Suzaki, H: 3 articles (05/2004 - 02/2001)|
|5.||Horio, T: 3 articles (01/2002 - 11/2001)|
|6.||Akamatsu, H: 3 articles (01/2002 - 11/2001)|
|7.||Iwata, Satoshi: 2 articles (07/2015 - 09/2005)|
|8.||Morimoto, Chikao: 2 articles (07/2015 - 09/2005)|
|9.||Dang, Nam H: 2 articles (07/2015 - 09/2005)|
|10.||Hosono, Osamu: 2 articles (07/2015 - 09/2005)|
08/01/1992 - "burgdorferi infection was established in gerbils; a dosage of greater than or equal to 25 mg/kg/day roxithromycin for 10 days eliminated the infection. "
11/01/1987 - "Roxithromycin should be considered as an effective and safe oral antibiotic to treat children with upper and lower respiratory tract and skin infections due to common pathogens."
04/01/1991 - "The clinical efficacy of a macrolide antibiotic, roxithromycin, was evaluated in 24 patients affected by acute odontogenic infections. "
04/01/1991 - "[The clinical efficacy of roxithromycin in patients with acute odontogenic infections]."
12/01/1992 - "To evaluate the clinical efficacy and tolerance of roxithromycin in the treatment of odontogenic infections, an open study was performed. "
|2.||Respiratory Tract Infections (Respiratory Tract Infection)
05/01/1992 - "The results indicate that both drugs are equally effective in the treatment of respiratory tract infection, but that roxithromycin is better tolerated."
05/01/1992 - "These results, allied with its improved pharmacokinetic properties, suggest that roxithromycin should be an effective treatment in children and adults for upper and lower respiratory tract infections caused by M. "
06/01/1991 - "[Efficacy of roxithromycin in the treatment of lower respiratory tract infections in patients with chronic respiratory disease]."
06/01/1998 - "A new paediatric formulation of roxithromycin was tested for acceptability, efficacy and safety in a multicentre, prospective, non-comparative trial in 210 children, aged between 2 and 8 years, with a variety of respiratory tract infections. "
04/01/1996 - "The study suggests that roxithromycin is an effective and well tolerated antibacterial in the treatment of lower respiratory tract infection."
03/01/1998 - "Roxithromycin thus appears to be an effective and well-tolerated drug for the treatment of acute and recurrent sinusitis."
02/01/1997 - "We studied the clinical efficacy of roxithromycin (RXM) administered at the daily dosage of one tablet (150 mg) for 3 months in 30 patients with chronic sinusitis. "
04/01/2009 - "[An empirical study of treating chronic sinusitis with low dose Roxithromycin]."
04/01/2009 - "Low dose Roxithromycin has good long term curative effect in treating chronic sinusitis. "
04/01/2009 - "Observe the therapeutic effect of low dose Roxithromycin in treating chronic sinusitis and further discuss the mechanism of Roxithromycin facile endothelial cell apoptosis. "
01/01/2004 - "We clinically evaluated roxithromycin (ROM) in a double blind, placebo-controlled, and crossover trial in patients with inflammatory acne. "
01/01/2004 - "Clinical evaluation of roxithromycin: a double-blind, placebo-controlled and crossover trial in patients with acne vulgaris."
01/01/1998 - "[Treatment of acne by using roxithromycin and a study of the mechanism of the drug action]."
07/01/2009 - "Roxithromycin has a therapeutic effect on inflammatory acne and leads to improvement of quality of life in the patients."
07/01/2009 - "Effects of oral antibiotic roxithromycin on quality of life in acne patients."
|5.||Asthma (Bronchial Asthma)
08/08/2003 - "A new macrolide, roxithromycin, may be an effective treatment for asthma. "
01/01/2014 - "The purpose of this study was to investigate the effect of roxithromycin on apoptosis of airway smooth muscle cells (ASMCs) from a rat model of asthma and uncover signaling pathway underlying the cytotoxicity of roxithromycin. "
01/01/2014 - "Roxithromycin induced apoptosis of ASMCs derived from a rat model of asthma in a dose-dependent manner via a caspase-3- and caspase-9-dependent mitochondrial pathway, involving the up-regulation of P27."
01/01/2014 - "ASMCs were isolated from a rat model of asthma and treated with or without roxithromycin for 48 h before parameter detection. "
01/01/2014 - "Roxithromycin reduces the viability of cultured airway smooth muscle cells from a rat model of asthma."
|7.||Anti-Bacterial Agents (Antibiotics)
|10.||Amoxicillin-Potassium Clavulanate Combination (Co-amoxiclav)
|2.||Drug Therapy (Chemotherapy)
|4.||Transplantation (Transplant Recipients)